{Reference Type}: Case Reports
{Title}: Antiretroviral therapeutic drug monitoring in a patient with small bowel resection and new HIV diagnosis.
{Author}: Cervino Ahern L;Nixon D;Fulco PP;
{Journal}: IDCases
{Volume}: 37
{Issue}: 0
{Year}: 2024
暂无{DOI}: 10.1016/j.idcr.2024.e02017
{Abstract}: Antiretroviral (ARV) absorption in persons living with human immunodeficiency virus (PLWH, HIV) with short bowel syndrome is limited. We describe a case of a 28-year-old male with newly diagnosed HIV and plasmablastic lymphoma with proximal jejunostomy necessitating parenteral nutrition. ARV therapy with dolutegravir 50 mg twice daily and once daily tenofovir/emtricitabine was initiated with documented malabsorption and delayed virologic suppression (VS). Dolutegravir dose titration with therapeutic drug monitoring (TDM) resulted in VS at month 12. ARV TDM with dose titration is an option for PLWH with malabsorptive states to maintain VS.